DAVID SCHENKEIN

Profile

First Name

: DAVID

Middle Name

:

Last Name

: SCHENKEIN

Related Companies

Titles

Company Name

Related People

EXECUTIVE OFFICER, DIRECTOR

AGIOS PHARMACEUTICALS INC

LEWIS C. CANTLEY, DOUG COLE, DUNCAN HIGGONS, PERRY KARSEN, JOHN MARAGANORE, ROBERT NELSEN, KEVIN STARR, MARC TESSIER-LAVIGNE

DIRECTOR

FOUNDATION MEDICINE, INC.

ALEXIS BORISY, ALEXIS BORISY, M.S., BROOK BYERS, ROBERT W. HESSLEIN, EVAN JONES, KEVIN KRENITSKY, KEVIN KRENITSKY, M.D., MARK LEVIN, MICHAEL J. PELLINI, MICHAEL PELLINI, M.D., JASON RYAN, ROBERT TEPPER, ROBERT TEPPER, M.D., KRISHNA YESHWANT

DIRECTOR

BLUEPRINT MEDICINES CORP

JEFFREY W. ALBERS, CHRISTINE BELLON, ALEXIS BORISY, STEPHEN KNIGHT, KYLE KUVALANKA, CHRISTOPH S. LENGAUER, NICHOLAS LYDON, NICK LYDON, DANIEL LYNCH, THILO SCHROEDER

DIRECTOR

TREELINE BIOSCIENCES, INC.

JOSHUA H. BILENKER, DAVID BONITA, KRISTINA BUROW, STEVEN ELMS, JEFFREY ENGELMAN, AFTAB KHERANI, AVI NAIDER, ALI SATVAT

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2025-08-21

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2024-10-02

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2022-09-26

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2021-04-09

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2014-11-10

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2014-01-06

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2012-09-10

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2012-09-10

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2011-11-16

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2011-08-08

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2010-04-14